​

Leap Therapeutics (LPTX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Leap Therapeutics Revenue Highlights

00

Main Segment (Y)

License

Main Geography (Y)

License

Leap Therapeutics Revenue by Period

Leap Therapeutics Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31--100.00%
2021-12-31$1.50M-
2020-12-31$1.50M100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31--

Leap Therapeutics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Leap Therapeutics Revenue by Quarter

DateRevenueChange
2025-09-30-100.00%
2025-06-30-100.00%
2025-03-31--100.00%
2024-12-31$10.00K100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$634.00K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31--100.00%
2021-12-31$375.00K-
2021-09-30$375.00K-
2021-06-30$375.00K-
2021-03-31$375.00K-
2020-12-31$375.00K-
2020-09-30$375.00K-
2020-06-30$375.00K-
2020-03-31$375.00K100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31--

Leap Therapeutics generated - in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Leap Therapeutics Revenue Breakdown

Leap Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 21Dec 20
Royalty--
License$1.50M$1.50M

Leap Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 21: License (100.00%).

Quarterly Revenue by Product

Product/ServiceDec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20
License$375.00K$375.00K$375.00K$375.00K$375.00K$375.00K$375.00K$375.00K
Royalty--------

Leap Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Dec 21: License (100.00%).

Leap Therapeutics Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 21Dec 20
Royalty--
License$1.50M$1.50M

Leap Therapeutics's latest annual revenue breakdown by geography, as of Dec 21: License (100.00%).

Quarterly Revenue by Country

CountryDec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20
License$375.00K$375.00K$375.00K$375.00K$375.00K$375.00K$375.00K$375.00K
Royalty--------

Leap Therapeutics's latest quarterly revenue breakdown by geography, as of Dec 21: License (100.00%).

Leap Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CRISCuris$10.91M$2.75M
DAREDaré Bioscience$9.78M$-21.17K
ICUSeaStar Medical$135.00K$338.00K
APLMApollomics--
CTXRCitius Pharmaceuticals--
ASBPAspire Biopharma--
BCTXBriaCell Therapeutics--
LPTXLeap Therapeutics--
ATHAAthira Pharma--
PCSAProcessa Pharmaceuticals--

LPTX Revenue FAQ

What is Leap Therapeutics’s yearly revenue?

Leap Therapeutics's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. LPTX's yearly revenue for 2022 was $0, representing a decrease of -100.00% compared to 2021.

What is Leap Therapeutics’s quarterly revenue?

Leap Therapeutics's quarterly revenue for Q3 2025 was $0, a 100.00% increase from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). LPTX's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024).

What is Leap Therapeutics’s revenue growth rate?

Leap Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was -100.00%.

What are Leap Therapeutics’s revenue streams?

Leap Therapeutics's revenue streams in c 21 are License

What is Leap Therapeutics’s main source of revenue?

For the fiscal year ending Dec 21, the largest source of revenue of Leap Therapeutics was License. This segment made a revenue of $1.5M, representing 100.00% of the company's total revenue.